Global Medical REIT Inc. (GMRE): Price and Financial Metrics
Global Medical REIT Inc. (GMRE)
Today's Latest Price: $14.13 USD
0.02 (-0.14%)
Updated Dec 10 6:30pm
Add GMRE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 16 in REITs - Healthcare
See all "A" rated Strong Buy stocks
GMRE Stock Summary
- GMRE's went public 3.44 years ago, making it older than merely 10.98% of listed US stocks we're tracking.
- Of note is the ratio of Global Medical REIT Inc's sales and general administrative expense to its total operating expenses; only 7.56% of US stocks have a lower such ratio.
- The ratio of debt to operating expenses for Global Medical REIT Inc is higher than it is for about 90.81% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Global Medical REIT Inc are CTRE, ROIC, INN, UE, and PGRE.
- To dig deeper into the stock's financial statements, go to GMRE's page on browse-edgar?action=getcompany&CIK=0001533615.
GMRE Daily Price Range
GMRE 52-Week Price Range
GMRE Stock Price Chart More Charts
GMRE Price/Volume Stats
| Current price | $14.13 | 52-week high | $14.26 |
| Prev. close | $14.15 | 52-week low | $8.15 |
| Day low | $14.06 | Volume | 196,150 |
| Day high | $14.26 | Avg. volume | 292,394 |
| 50-day MA | $12.44 | Dividend yield | 5.65% |
| 200-day MA | $11.00 | Market Cap | 513.94M |
Global Medical REIT Inc. (GMRE) Company Bio
Global Medical REIT engages primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to leading clinical operators. The company was founded in 2011 and is based in Bethesda, Maryland.
Top Stories View All
Why Investors Should be Bullish About GW Pharmaceuticals (GWPH)
Why I Believe Facebook (FB) is Headed Higher
Best & Worst Performing Stock Industries for December 10, 2019
Best & Worst Performing Small Cap Stocks for December 10, 2019
Best & Worst Performing Mid Cap Stocks for December 10, 2019
View All Top Stories
Loading social stream, please wait...